Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Chengdu, Sichuan, China

    Main Sales Markets: Central/South America,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    • Name: Human Hepatitis B Immunoglobulin

    • Category: Hematology, Critical Illness

    • Specifications:

      • 100IU/vial (100IU/ml, 1ml)

      • 200IU/vial (100IU/ml, 2ml)

      • 400IU/vial (100IU/ml, 4ml)

    • Approval Numbers:

      • 100IU/vial (100IU/ml, 1ml) - NMPA Approval No. S19993044

      • 200IU/vial (100IU/ml, 2ml) - NMPA Approval No. S19993045

      • 400IU/vial (100IU/ml, 4ml) - NMPA Approval No. S19993046

    • Indications: Prevention of hepatitis B. Infants born to hepatitis B surface antigen (HBsAg)-positive mothers./Individuals at risk of accidental infection./Individuals with close contact to hepatitis B patients or carriers of the hepatitis B virus.
    •  

Send your message to this supplier
  • From:
  • To:
    Grand Shuyang Life Sciences (Chengdu) Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service